RxDoctor Payments Data

Rachelle Frost, NP

Nurse Practitioner · Provo, UTNPI 1730105214

Payments from drug & device makers

$1,256in general payments, 2019–2025

Across 60 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$271
  • Amgen$189
  • Boston Scientific$111
  • Boehringer Ingelheim$106
  • Pfizer$92
  • Actelion Pharmaceuticals US, Inc.$87
  • plus $400 from 13 others

What the payments were for

  • Food & beverage$1,256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,256 in reported general payments places this provider in the 80th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$49,396
Medicare patients
267
Services billed
710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban133$138,507
EntrestoSacubitril/Valsartan57$49,411
XareltoRivaroxaban28$29,123
JardianceEmpagliflozin30$18,626
FarxigaDapagliflozin Propanediol23$16,588
MounjaroTirzepatide13$13,477
Atorvastatin Calcium230$2,607
Flecainide Acetate71$2,476
Metoprolol Succinate141$1,745
Rosuvastatin Calcium121$1,719
Losartan Potassium134$1,482
Ranolazine ErRanolazine26$1,364
Carvedilol133$1,241
Amiodarone Hcl32$1,125
ClopidogrelClopidogrel Bisulfate76$1,024

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$92$138,507133 claims
NovartisEntresto$271$49,41157 claims
Johnson & JohnsonXarelto$76$29,12328 claims
Boehringer IngelheimJardiance$106$18,62630 claims
AstraZenecaFarxiga$16$16,58823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →